https://www.selleckchem.com/products/AT7867.html
Findings also explore the dialectical nature of settings as both empowering and disempowering. Implications for future interventions are discussed. Outcomes are unpredictable for neurological presentations of Wilson's disease (WD). Dosing regimens for chelation therapy vary and monitoring depends on copper indices, which do not reflect end-organ damage. To identify a biomarker for neurological involvement in WD. Neuronal and glial-specific proteins were measured in plasma samples from 40 patients and 38 age-matched controls. Patients wer
お気に入り
コメント
シェア
